Physician profile
Angela Mitchell
NPI 1205521028
$1,386.76
in general payments reported to CMS, 2019-2025
13 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $541 · 2024: $599 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,287.76 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $289.93 | 2023-2025 | Veozah |
| Abbvie INC. | $238.64 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $130.75 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2024 | Relistor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.97 | 2024 | Jardiance |
| Medtronic, INC. | $122.81 | 2023 | Interstim |
| Otsuka America Pharmaceutical, INC. | $109.80 | 2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $85.34 | 2024 | Austedo Xr |
| Organon LLC | $41.21 | 2024 | |
| Pfizer INC. | $39.91 | 2024 | |
| Solventum Corporation | $29.73 | 2024 | Prevena |
| Exeltis, USA INC. | $24.61 | 2025 | Slynd |
| Vertex Pharmaceuticals Incorporated | $24.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.